"We found that a lot of the wounds we were closing were wounds that had already been closed in the past. It became clear to us that if our technology could be used to close the wounds, why wouldn't we use [it] to prevent the wound from opening in the first place?"

— Alden Rattew, executive VP at Canica, discussing his company's reasoning for developing its SutureSafe product, a non-invasive, adhesive-based wound care device which applies as simply as a bandage, bridging the wound line over sutures or staples, "SutureSafe expected to get a thumbs-up from patients."

No Comments